NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children’s Hospital Recognized for Excellence in Life Support
Prestigious Critical Care Award Recognizes Use of Life-Saving ECMO Treatment
NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children’s Hospital have earned the Gold Level Excellence in Life Support Award from the Extracorporeal Life Support Organization (ELSO), a consortium of healthcare professionals and scientists dedicated to the development and evaluation of novel therapies for the support of failing organ systems.
The NewYork-Presbyterian campuses are two of a select few national and international Extracorporeal Life Support (ECLS) centers to receive the Excellence in Life Support Award for the award period 2015-2018. ELSO evaluates each center on a variety of evidence-based processes and quality measures, staff training and continuing education, patient satisfaction and ongoing clinical care.
“We are proud to receive this important recognition, but even more proud of the commitment it represents by our entire team to providing exceptional care in even the most challenging circumstances,” said Dr. William Middlesworth, director of the Pediatric Extracorporeal Membrane Oxygenation Program at NewYork-Presbyterian/Columbia University Medical Center.
NewYork-Presbyterian Hospital is committed to providing world-class life support for all of its patients. The ECMO program at NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children’s Hospital is one of the largest and most successful programs in the world providing ECMO, or Extracorporeal Membrane Oxygenation, to patients with respiratory or cardiac failure. ECMO allows time for the patient’s lungs or heart to heal by using a version of a heart-lung machine to provide oxygen to the blood outside the body.
Hundreds of critically-ill patients have been referred to NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children’s Hospital as potential ECMO patients from many hospitals throughout the mid-Atlantic region. For some patients, ECMO may even be initiated at the referring hospital for transport back to NewYork-Presbyterian.
NewYork-Presbyterian Hospital, based in New York City, is one of the nation’s largest and most comprehensive hospitals and a leading provider of inpatient, ambulatory and preventive care in all areas of medicine. With some 2,600 beds and more than 6,700 affiliated physicians and almost 22,000 employees, NewYork-Presbyterian had more than 2 million visits in 2014, including some 14,000 infant deliveries and more than 262,000 emergency department visits. NewYork-Presbyterian comprises six campuses: NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children's Hospital, NewYork-Presbyterian/The Allen Hospital, NewYork-Presbyterian/Westchester Division and NewYork-Presbyterian/Lower Manhattan Hospital. The hospital is also closely affiliated with NewYork-Presbyterian/Hudson Valley Hospital, NewYork-Presbyterian/Lawrence Hospital and NewYork-Presbyterian/Queens. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area, according to U.S. News & World Report, and consistently named to the magazine’s Honor Roll of best hospitals in the nation. Affiliated with two world-renowned medical schools, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, NewYork-Presbyterian is committed to excellence in patient care, research, education and community service. For more information, visit www.nyp.org.
Public Affairs 212-821-0560 [email protected]